APOG surges on $1.3B deal
Apogee Therapeutics shares rise after securing a $1.3 billion financing partnership with Blackstone, boosting the company's growth prospects. The deal is expected to support APOG's development pipeline.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.